Evidence map›Paper›PMID 1557405›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1992

Nucleoplasmic localization of prelamin A: implications for prenylation-dependent lamin A assembly into the nuclear lamina.

R J Lutz, M A Trujillo, K S Denham, L Wenger, M Sinensky

Erratum issuedAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Skin Disease in Laminopathy-Associated Premature Aging.The Journal of investigative dermatology · 2015
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Targeting protein prenylation in progeria.Science translational medicine · 2013
    Review
  17. Article
  18. Article
  19. Review
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

5 authors.

R J LutzEleanor Roosevelt Institute for Cancer Research, Denver, CO 80206.
M A Trujillo
K S Denham
L Wenger
M Sinensky

Funding

BIOCHEMICAL GENETICS OF CELLULAR CHOLESTEROL METABOLISMR01DK040804 · NIDDK · ELEANOR ROOSEVELT INST FOR CANCER RES · PI SINENSKY, MICHAEL S · 1989 to 1993
–
NIDDK NIH HHS DK40804
6 · The paper itself

Abstract

The synthesis of the nuclear lamina protein lamin A requires the prenylation-dependent processing of its precursor protein, prelamin A. Unlike p21ras, which undergoes similar initial posttranslational modifications, maturation of lamin A results in the proteolytic removal of the prenylated portion of the molecule. We have used an in vitro prenylation system to demonstrate the nature of the prenyl substituent on prelamin A to be a farnesyl group. Further, the in vitro farnesylation of prelamin A requires an intact cysteine-aliphatic-aliphatic-other (CAAX) amino acid sequence motif at its carboxyl terminus. The effect of blocking the prenylation of prelamin A on its localization and assembly into the nuclear lamina was investigated by indirect immunofluorescence. Expression of wild-type prelamin A in lovastatin-treated cells showed that nonprenylated prelamin A accumulated as nucleoplasmic particles. Upon addition of mevalonate to lovastatin-treated cells, the wild-type lamin A was incorporated into the lamina within 3 hr. Expression of a mutant lamin A in which the carboxyl-terminal 21 amino acids were deleted resulted in a lamin molecule that was directly assembled into the lamina. These results indicate that the carboxyl-terminal peptide of prelamin A blocks its proper assembly into the nuclear lamina and that the prenylation-initiated removal of this peptide can occur in the nucleus.

Indexed as

AnimalsCell CompartmentationCell NucleusCHO CellsCricetinaeFarnesolLaminsLamin Type ALovastatinNuclear EnvelopeNuclear ProteinsProtein PrecursorsProtein Processing, Post-TranslationalRecombinant ProteinsStructure-Activity RelationshipFarnesolLaminsLamin Type ALovastatinNuclear ProteinsProtein PrecursorsRecombinant Proteins

Identifiers

PMID1557405
PMCPMC48791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.